Figure 2C,D shows substantial NMO-IgG deposition in optic nerves, with focal loss of AQP4 immunoreactivity, cell infiltration, and deposition of activated complement, indicating access of NMO-IgG and complement to the optic nerve, with development of NMO-like pathology. The gene discussed is AQP4; the disease is neuromyelitis optica.